Search

everythinglearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Recognizing new allergens can help reduce contact dermatitis cases.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Adiponectin reduces inflammation and bone loss in joint replacements.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

Finger length ratios might predict risk for skin condition in males.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Hair transplants are effective for male and female pattern baldness, have evolved in technique, and require careful planning for natural results and managing complications.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Improved hair loss treatment using special particles and surfactants.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Both 1565-nm laser and 1064-nm laser safely and effectively reduce enlarged facial pores, with the 1064-nm laser causing fewer side effects.